ABVC BioPharma Receives Notice of Allowance from US Patent

FREMONT, CA, Nov. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company...

Related Keywords

Fremont ,California ,United States ,Australia ,Taiwan ,Japan ,China ,Stanford University ,Howard Doong ,Leeds Chow ,European Patent Office ,Sinai Medical Center ,Nasdaq ,Biopharma Inc ,Exchange Commission ,Trademark Office ,Company Annual Report On Form ,University Of California At San Francisco ,Major Depressive Disorder ,Radix Polygalae ,Patent Cooperation Treaty ,Antidepressant Drugs Market ,San Francisco ,Cedars Sinai Medical Center ,For Vitargus ,Annual Report ,Quarterly Reports ,Nasdaq Abvc ,Abvc Biopharma ,Nc ,Otice Of Allowance ,Us Patent And Trademark Office ,